1007884-61-8

Basic information

• Product Name: benzyl 2-(3,3-dimethylureido)-3-methylbutanoate
• Synonyms: benzyl 2-(3,3-dimethylureido)-3-methylbutanoate
• CAS NO: 1007884-61-8
• Molecular Formula: C₁₅H₂₂N₂O₃
• Molecular Weight: 278.34678
• Mol File: 1007884-61-8.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• CAS DataBase Reference: benzyl 2-(3,3-dimethylureido)-3-methylbutanoate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 2-(3,3-dimethylureido)-3-methylbutanoate(1007884-61-8)
• EPA Substance Registry System: benzyl 2-(3,3-dimethylureido)-3-methylbutanoate(1007884-61-8)

Safety Data

• Hazardous Substances Data: 1007884-61-8(Hazardous Substances Data)

Upstream product

• 21760-98-5 L-valine benzyl ester 
• 79-44-7 N,N-Dimethylcarbamoyl chloride 
• 2462-34-2 L-valine benzyl ester hydrochloride 

Relevant articles and documents

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

HEPATITIS C VIRUS INHIBITORS

This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.